Ensuring Investments In TB R&D Critical To Confronting Drug Resistance

PLOS Blogs’ “Speaking of Medicine”: Why Tuberculosis is an R&D priority
On World TB Day, which takes place annually on March 24, Grania Brigden, lead of the 3P Project at the International Union Against TB and Lung Disease, discusses the importance of developing new treatments for TB and highlights a new funding mechanism, the 3P Project, which aims to “incentivize collaboration research, reward investment in TB R&D, and develop shorter [TB treatment] regimens” (3/24).